For citations:

Antipova L.A., Loria S.S., Semochkin S.V., Rumiantsev A.G. Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®). Oncohematology. 2009;(1):14-20. (In Russ.) https://doi.org/10.17650/1818-8346-2009-0-1-14-20